Calidi Biotherapeutics is a clinical-stage biotechnology company at the forefront of oncolytic virus-based immunotherapies for cancer.
Calidi Biotherapeutics is a clinical-stage immuno-oncology company with proprietary technology that is revolutionizing the utilization of oncolytic viruses through an allogeneic cell-based delivery system.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jan 21, 2020 | Convertable Note | $8.17M | 2 | — | — | Detail |
|
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
|---|---|---|---|---|
|
Nov 16, 2022
Virtualness
|
Seed | $8M | Information Technology | — |
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
— | Convertable Note |
|
|
— | Convertable Note |